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Abstract 1 
Abamectin is one of the most widely used avermectins for agricultural pests control，but the 2 
emergence of resistance around the world is proving a major threat to its sustained application. 3 
Abamectin, acts by direct activating glutamate-gated chloride channels (GluCls) and 4 
modulating other Cys-loop ion channels. To date, three mutations occurring in the 5 
transmembrane domain of arthropod GluCls are associated with target-site resistance to 6 
abamectin: Aγ09V in Plutella xylostella GluCl (PxGluCl), GγβγD in Tetranychus urticae 7 
GluCl1 (TuGluCl1) and Gγβ6E in TuGluClγ. To compare the effects of these mutations in a 8 
single system, Aγ09V/I/G and Gγ15E (corresponding to Gγβγ in TuGluCl1 and Gγβ6 in 9 
TuGluClγ) substitutions were introduced individually into the PxGluCl channel. Functional 10 
analysis using Xenopus oocytes showed that the Aγ09V and Gγ15E mutations reduced the 11 
sensitivity to abamectin by 4.8- and 49γ-fold, respectively. In contrast, substitutions Aγ09I/G 12 
show no significant effects on the response to abamectin. Interestingly, the Aγ09I substitution 13 
increased the channel sensitivity to glutamate by one order of magnitude (c.a.1β-fold). 14 
Analysis of PxGluCl homology models indicates that the Gγ15E mutation interferes with 15 
abamectin binding through a steric hindrance mechanism. In contrast the structural 16 
consequences of the Aγ09 mutations are not so clear and an allosteric modification of the 17 
binding site is the most likely mechanism. Overall the results show that both Aγ09V and 18 
Gγ15E mutations may contribute to target-site resistance to abamectin, and could impact 19 
future prediction and monitoring of abamectin resistance in P. xylostella and other arthropod 20 
pests. 21 
 22 
Keywords: Abamectin, Glutamate-gated chloride channel, Target-site resistance, Molecular 23 
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 25 
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1. Introduction  1 
 Avermectins are naturally occurring 16-membered macrocyclic lactones produced by 2 
fermentation of the soil-dwelling microorganism Streptomyces avermitilis. These compounds 3 
have potent activity against many kinds of endoparasitic nematodes and ectoparasitic 4 
arthropods (Campbell, β01β). Since their first isolation in the 1970’s, they have been applied 5 
globally for crop protection and animal health purposes. Among the avermectin family 6 
members, abamectin (avermectin B1) is one of the most widely used compounds for 7 
agricultural pest management (Clark et al., 1995), and ivermectin (a synthetic derivative of 8 
avermectin B1, IVE) is active at extremely low dosage against a range of nematode and 9 
arthropod parasites (Campbell et al., 198γ). Avermectins are classified as neurotoxins, which 10 
act by directly activating or potentiating glutamate-gated chloride channels (GluCls) (and to a 11 
lesser extent Ȗ-amino butyric acid (GABA)-gated chloride channels). GluCls contribute 12 
extensively to invertebrate nervous system function, including modulating locomotion, 13 
regulating feeding and mediating sensory inputs (Wolstenholme, β01β) and so modification of 14 
channel function by avermectins action can result in paralysis and death (Bloomquist, 1996, 15 
β00γ).  16 
 GluCls belong to the Cys-loop superfamily of ligand-gated ion channels that assemble as 17 
pentamers to form a central ion-conducting pore; these GluCl receptors are present only in 18 
invertebrates (Jones and Sattelle, β008; Wolstenholme, β01β). GluCls were first described in 19 
electrophysiological studies on locust muscle, when a biphasic change in its membrane 20 
potential was recorded and glutamate-enhanced chloride permeability resulted in the 21 
hyperpolarizing phase (Cull-Candy, 1976). The first cloned genes encoding GluCl subunits 22 
were glucl-α and glucl-ȕ (now referred to glc-1 and glc-2, respectively) from the nematode 23 
Caenorhabditis elegans. When expressed in Xenopus oocytes GluCls composed of glucl-α 24 
subunits were response to IVE but not to L-glutamate whereas conversely homomeric glucl-ȕ 25 
channels were unresponsive to IVE but were activated by L-glutamate (Cully et al., 1994; 26 
Daeffler et al., β014). The co-expression of both α and ȕ subunits produced channels that 27 
robustly responded to both glutamate and IVE independently and so more closed resembled 28 
the naturally-occurring receptor (Cully et al., 1994; Vassilatis et al., 1997; Slimko et al., β00β; 29 
 4
Degani-Katzav et al., β016). The C. elegans GluCl gene family has since been expanded to 1 
six members (Jones and Sattelle, β008). Genomic analysis has shown that a single GluCl gene, 2 
with variant transcripts produced by mRNA splicing and extensive editing, is present in 3 
several insects, including Drosophila melanogaster, Apis mellifera, Nasonia vitripennis, and 4 
Tribolium castaneum (Semenov and Pak, 1999; Jones and Sattelle, β006, β007; Jones et al., 5 
β010; Knipple and Soderlund, β010). Multiple GluCl genes have been identified in other 6 
organisms: two in Aplysia californica, six in Tetranychusur ticae and one in Lepeophtheirus 7 
salmonis (Tribble et al., β007; Kehoe et al., β009; Dermauw et al., β01β).  8 
 Several experiments based on functional analysis of IVE-resistant GluCl channels in 9 
nematodes predicted that IVE acts by insertion between transmembrane domain of GluCls 10 
(Dent et al., β000; Njue et al., β004). Recently, our knowledge of the structural and functional 11 
properties of the GluCls has made a greatly enrich attribute to development of the 12 
three-dimensional crystallographic structure of C. elegans GluClα channel (CeGluClα), which 13 
presented the first high-resolution view of a eukaryotic Cys-loop receptor (Hibbs and Gouaux, 14 
β011). This X-ray structure revealed that GluCls are arranged with five-fold symmetry and the 15 
transmembrane Mβ helices form the pore lumen. The pore-lining residues of the Mβ helices 16 
therefore determine the ion selectivity and conductance properties of the channel (Hibbs and 17 
Gouaux, β011). This structure was co-crystallized with IVE, which binds in the 18 
transmembrane domain at subunit interfaces, lying between Mγ and M1 helices of two 19 
adjacent subunits and making binding contacts with Mβ and the Mβ-Mγ loop. The 20 
endogenous ligand glutamate binds in the extracellular domain of the receptor in the classical 21 
neurotransmitter position, which is also located at the interface of adjacent subunits.  22 
 The diamondback moth, Plutella xylostella, is one of the few insect species that has 23 
evolved field resistance to all primary classes of insecticides (Furlong et al., β01γ). As such it 24 
represents a valuable agricultural pest model to study the genetics and mechanisms of 25 
resistance development (Furlong et al., β01γ). Gene mutations mediated resistance 26 
mechanism has been widely studied in P. xylostella, occurred in acetylcholinesterase, sodium 27 
channel, nicotinic acetylcholine receptor, GluCl, ryanodine receptor and ABC transporter Cβ, 28 
which involved in resistance to organophosphorous, pyrethroid, spinosad, abamectin, 29 
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chlorantraniliprle, Bt Cry1Ac toxin, indoxacarb and metaflumizone, respectively (Schuler et 1 
al., 1998; Lee et al., β007; Baxter et al., β010, β011; Troczka et al., β01β; Guo et al., β014; 2 
Wang et al., β016a, β016b, β016c). Abamectin has been used for P. xylostella control since the 3 
1980’s and at least 7β cases from four countries have been reported of field resistance to this 4 
chemical (APRD, β017). A detailed study of the molecular mechanisms of abamectin 5 
resistance is important for designing strategies to circumvent it. In our previous work, a 6 
combination of genetics and sequencing identified a point mutation (Aγ09V) in the 7 
transmembrane domain of P. xylostella glutamate-gated chloride channel receptor, PxGluCl, 8 
which has been evaluated to contribute c.a. 10-fold increase to abamectin resistance in the 9 
resistant Roth-Abm strain (Wang et al., β016b). We believe that characterizing the 10 
pharmacological properties of this mutation that evolved in PxGluCl could help in exploring 11 
the resistance mechanisms in this and other species and might inform the development of new 12 
macrocyclic lactones insecticides. 13 
 In addition to Aγ09V, only three other mutations in GluCls have been reported in 14 
association with resistance to avermectins (IVE & abamectin) in other arthropods (Fig. 1). 15 
The Pβ99S mutation of the D. melanogaster DmGluCl channel is associated with a γ-fold 16 
resistance to IVE in this insect (Kane et al., β000). The TuGluCl1 GγβγD and TuGluClγ 17 
Gγβ6E mutations are associated with 18- and β000-fold resistance to abamectin in T. urticae, 18 
respectively (Kown et al., β010; Dermauw et al., β01β). Of these only the Pβ99S mutation has 19 
been characterized electrophysiologically and a 14-fold reduction in IVE sensitivity was 20 
found when this substitution was introduced into DmGluCl (Kane et al., β000). In the current 21 
study, we expressed Aγ09V or Gγ15E (equivalent to Gγβγ in TuGluCl-1 and Gγβ6 in 22 
TuGluCl-γ) mutants of PxGluCl in Xenopus laevis oocytes and compared their functional 23 
properties with wild-type receptors. Also, further mutations of Aγ09 to glycine or isoleucine 24 
were generated to investigate how substitutions at this position on the Mγ helix could affect 25 
glutamate or abamectin binding. Homology models were generated to provide structural 26 
insight into the molecular mechanisms that underlie the abamectin resistance of these 27 
mutations.  28 
2. Materials and methods 29 
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2.1. Chemicals and reagents 1 
 L-Glutamic acid (≧99%) and abamectin (B1a = 91.5%), used for two-electrode 2 
voltage-clamp recording, were purchased from Sigma-Aldrich (St. Louis, MO, USA) and 3 
Veyong bio-chemical (Shijiazhuang, Hebei, China), respectively. All the restricted enzymes 4 
used in this study, including EcoRI, XbaI, SmaI, NotI and the klenow fragment were 5 
purchased from Thermo Fisher Scientific (Waltham, MA, USA). 6 
2.2. Site-directed mutagenesis and cRNA synthesis 7 
 Total RNA of 4th-instar larvae from P. xylostella susceptible Roth strain was extracted by 8 
using the SV Total RNA Isolation System Kit (Promega, Madison, WI, USA) according to the 9 
manufacturer’s protocol. First-strand cDNA was synthesized from 1 μg total RNA using an 10 
oligo(dT)15 primer and M-MLV reverse transcriptase (Promega, Madison, WI, USA). The 11 
full-length cDNA of wild-type PxGluCl (GenBank accession no. JX014βγ1.1) was amplified 12 
by PrimeSTAR HS DNA polymerase (TaKaRa, Japan) and PCR (γ5 cycles of 98 °C for 10 s, 13 
5γ °C for 15s, and 7β °C for 90 s) with the forward primer PxGluCl_EcoRⅠ_F and the 14 
corresponding reverse primer PxGluCl_XbaⅠ_R (Table 1). Site-directed mutagenesis was 15 
performed by fusion PCR with wild-type PxGluCl cDNA as the template. All the cDNA 16 
constructs were ligated into the pEASY-Blunt Cloning vector (Beijing TransGen Biotech Co. 17 
Ltd, Beijing, China) and the isolated plasmid DNAs were examined by nucleotide sequencing 18 
(Life Technology, Shanghai, China). Five full-length P. xylostella GluCl cDNA (wild-type, 19 
Aγ09V, Aγ09I, Aγ09G and Gγ15E) were subcloned into the pGH19 vector, a modified 20 
version of plasmid pGEMHE，which contains 5´- and γ´-untranslated X. laevis beta-globin 21 
gene regions, and the presence of the mutations/substitutes were reconfirmed by sequencing. 22 
Plasmids were linearized with NotI, and capped RNAs were carried out using the T7 23 
mMessage mMachine Kit (Ambion, Life Technologies, Paisley, UK) according to the 24 
manufacturer’s instruction. Synthesized cRNAs were recovered by precipitation with 25 
isopropanol, dissolved in nuclease-free water at a final concentration of 500 ng/μL and stored 26 
at -80 °C until use. 27 
2.3. Functional expressions of PxGluCl variants in X. laevis oocytes 28 
 7
 Mature healthy X. laevis oocytes (stage V–VI) were treated with collagenase (type IA; β 1 
mg/ml; Sigma, USA) in calcium-free Barth’s solution (88 mM NaCl, β.4 mM NaHCOγ,15 2 
mM Tris-HCl, 1 mM KCl and 0.8β mM MgClβ) for about β5 min at room temperature, rinsed 3 
three times, and manually defolliculated before injection with cRNA. Oocytes were injected 4 
with 5-15 ng cRNA in a volume of γβ.β nL into the cytoplasm by using a Drummond variable 5 
volume microinjector. After injection, calcium-containing Barth’s solution (0.77 mM) with 6 
antibiotics (100 units/mL penicillin, 100 μg/mL streptomycin, 4 μg/mL kanamycin and 50 7 
μg/mL tetracycline) was used for oocytes’ incubation at 18 °C. Experiments were carried out 8 
at room temperature between γ and 5 days after injection. 9 
2.4. Two-electrode voltage clamp electrophysiology 10 
 Two-electrode voltage clamp was used for recording whole-cell currents from the 11 
injected Xenopus oocytes. The oocytes were held in a recording bath and continuously 12 
perfused with a Ringer’s solution (115 mM NaCl, β.5 mM KCl, 1.8 mM CaClβ and 10 mM 13 
Hepes, pH 7.γ). The glass capillary electrodes were filled with γM KCl and have a resistance 14 
of 0.5-1.5 MΩ. Glutamate and abamectin induced inward currents were recorded with an 15 
OC-7β5C oocyte clamp (Warner Instruments, Hamden, CT, USA) at a holding potential of -60 16 
mV. Data acquisition and analysis were carried out using iWorx 408 data acquisition system 17 
and LabScribe software (iWorx Systems, Inc. Dover, NH, USA). Glutamate was dissolved in 18 
Ringer’s solution and applied to the oocytes for γ s. After the glutamate perfusion, the oocytes 19 
were washed by Ringer’s solution for β min to assess their reproducibility. Abamectin was 20 
first dissolved in DMSO (0.1 mM) and then diluted with Ringer’s solution. The abamectin 21 
solution containing ≤ 0.1% DMSO was applied to oocytes for 15 s, and the oocytes were then 22 
washed for γ.5 min. Because of the effects of abamectin was irreversible, activated currents 23 
were normalized to the saturating glutamate-induced current in the same oocyte. 24 
Dose-response data were analyzed by nonlinear regression analysis using GraphPad Prism 5.0 25 
(GraphPad Software Inc., San Diego, CA, USA). Data were obtained for at least four oocytes 26 
from at least two frogs, and the values are given as means ± SEM. Statistical analysis was 27 
determined by a two-tail Student’s t-test. 28 
2.5. Homology modeling of PxGluCl mutants 29 
 8
 An homology model of the open-state P. xylostella glutamate-gated chloride channel 1 
(GenBank accession no. JX014βγ1.1) was generated as described (Wang et al., β016b). A 2 
docking prediction of avermectin B1a with the open-state P. xylostella open-state model was 3 
also previously generated (Wang et al., β016b). In this study, mutations were introduced into 4 
the channel model using Swiss-PdbViewer software (Guex et al., 1999) followed by γ0 steps 5 
of steepest descent then 50 steps of conjugate gradient energy minimization. Figures were 6 
produced using PyMOL (DeLano Scientific, San Carlos, CA, USA). 7 
2.6. Genomic DNA extraction and mutations screening of PxGluCl in field populations 8 
 To determine whether the Aγ09V and Gγ15E mutations of PxGluCl have evolved in field 9 
population of P. xylostella, PCR amplification was carried out with genomic DNA isolated 10 
from individual larvae using the AxyPrep™Multisource Genomic DNA Miniprep Kit 11 
(Axygen Biosciences, Union, CA, USA) according to the manufacturer's protocol. A genomic 12 
DNA fragment of PxGluCl, covering the Mγ region, was amplified as described previously 13 
(Wang et al., β016b). β0-40 samples from seventeen P. xylostella populations collected in 14 
China during β01γ-β015 were successful examined by direct nucleotide sequencing using a 15 
gene-specific primer (Wang et al., β016b). The genotypes of γ09 and γ15 positions of the 16 
PxGluCl were identified according to sequence chromatograms. 17 
3. Results 18 
3.1. Response of wild-type and mutant channels to glutamate 19 
 We cloned the full-length cDNA sequence of wild-type PxGluCl (the most common 20 
isoform γc9a) from the susceptible Roth strain. The natural-occurring mutations 21 
PxGluCl-Aγ09V (found in P. xylostella by Wang et al., β016b) and PxGluCl-Gγ15E 22 
(equivalent to Gγβ6E mutation found in T. urticae by Dermauw et al., β01β) were then 23 
introduced and two other mutants (PxGluCl-Aγ09I, PxGluCl-Aγ09G) were generated (Table 24 
1 and Fig. 1). The application of glutamate to these five channels induced robust inward 25 
currents in a dose-dependent fashion (Fig. β). The dose-response curves gave EC50s of 19.9γ 26 
± γ.β6 μM, 1γ.β4 ± 1.05μM, 1.67 ± 0.β0μM，γ4.60 ± β.8γμM and 10.γ5 ± γ.67μM for 27 
wild-type, Aγ09V, Aγ09I, Aγ09G and Gγ15E channels, respectively, and they produced nHs 28 
 9
of 1.75 ± 0.18, 0.98 ± 0.06, β.47 ± 0.γ1,0.70 ± 0.05 and 1.0γ ± 0.09 for wild-type, Aγ09V, 1 
Aγ09I, Aγ09G and Gγ15E channels, respectively (Table β). The Aγ09V and Gγ15E increased 2 
the potency of glutamate by 1.5- and 1.9-fold, respectively, without significant differences 3 
observed in EC50s when compared with the wild-type channel. 4 
 Interestingly, the Aγ09I mutant exhibited an approximately 1β-fold increase in glutamate 5 
sensitivity (Fig. βB), and the difference of EC50s and nHs between Aγ09I and wild-type 6 
channel were significant (p < 0.05). In contrast, the Aγ09G mutant was less sensitive to 7 
glutamate, with a 1.7-fold reduction compared with wild-type. The Hill coefficient for the 8 
Aγ09I and Aγ09G mutants was β.5 and 0.7, respectively, which suggests that the number of 9 
occupiable glutamate-binding sites in these receptors changed compared to wild-type. 10 
3.2. Response of wild-type and mutant channels to abamectin 11 
 Unlike the glutamate response, application of abamectin induced slow-to-activate and 12 
irreversible currents (Fig. γA), and it was observed in all channels in a dose-dependent 13 
manner (Fig. γB). The current did return to original baseline even after washing for several 14 
minutes with Ringer’s solution. The EC50s of abamectin calculated from the dose-response 15 
relationships of wild-type, Aγ09V, Aγ09I, Aγ09G and Gγ15E channels were 0.16 ± 0.05μM, 16 
0.78 ± 0.0β μM, 0.β5 ± 0.01μM, 0.15 ± 0.0β μM and 80.γβ ± βγ.67 μM, respectively (Table 17 
β). The results showed that the curve for abamectin was right-shifted in Aγ09V (Fig. γB), and 18 
the EC50 reduced 5.0-fold but significantly (p = 0.0β84), when compared with that of the 19 
wild-type. However, both of the Aγ09I and Aγ09G mutated channels had similar EC50 values 20 
(p > 0.05) to that wild-type channel (Table β and Fig. γB). 21 
 In contrast, the Gγ15E channel showed greatly reduced sensitivity to abamectin, yielding 22 
a 49γ-fold right-shift of EC50 compared with that of wild-type (Table β and Fig. γB), and the 23 
observed reduction of EC50 between Gγ15E and wild-type channel were significantly different 24 
(p = 0.017γ). Especially, the response of Gγ15E channel to the highest concentration of 25 
abamectin used in this study (0.γ mM), reached only 6γ ± 4.1% of the response to saturating 26 
glutamate-activated current (0.1 mM). It is therefore predicted that the Gγ15E mutation in 27 
PxGluCl may abolish abamectin potency. 28 
 10 
3.3. Molecular models of PxGluCl mutants 1 
 A model of PxGluCl in the open state and in complex with abamectin was previously 2 
generated (Wang et al., β016b) using the crystal structure of CeGluClα in complex with IVE 3 
(Hibbs and Gouaux, β011) as the homology template. As found previously with the Aγ09V 4 
mutation, there were no steric clashes encountered when Aγ09 was substituted with either 5 
glycine or isoleucine (Fig. 4). Furthermore, even introduction of the larger isoleucine 6 
side-chain did not result in novel binding contacts forming with abamectin. This is due to the 7 
register of the Mγ helix whereby the γ09 side chain is orientated away from the insecticide 8 
binding site (Fig. 4).  9 
    Gγ15 is also located on Mγ but, in contrast to Aγ09, the side chain of this residue is 10 
orientated towards the ligand binding domain (Fig. 5). This glycine is predicted to form van 11 
der Waals interactions with abamectin, which is also found with IVE and the conserved Mγ 12 
glycine in the open-state CeGluClα structure (Hibbs and Gouaux, β011). The effect of the 13 
Gγ15E mutation was to produce a major steric clash with the benzofuran moiety of abamectin 14 
(Fig. 5).  15 
3.4. Mutation screening in field populations 16 
 As has been described in Wang et al. (β016b), we have established a rapid detection 17 
method for the mutation occurred in Mγ by using the direct-sequencing chromatograph. The 18 
Aγ09V mutation was first identified in Roth-Abm, which was obtained from a field 19 
population TH with high-level of abamectin resistance (Pu et al., β010), indicating that 20 
Aγ09V was present in the field. Both TH1γ and TH16 were also collected in β01γ and β016 21 
from Tonghai County, Yunnan Province, China. Genotype detection has revealed that TH16 22 
population consisted of 16 homozygous wild-type (Ala at position γ09) and 4 heterozygous 23 
(Ala/Val) individuals, and the mutant frequency reached to 10% (Table γ). TH1γ population 24 
collected βyrs ago had also been detected carrying 6.β5% mutant alleles. By contrast, five 25 
populations from Southeast China, which evolved high levels of resistance to abamectin (49- 26 
to β5γ-fold, unpublished data), but the Aγ09V mutation was not detected in these populations. 27 
However, β of 8 populations (KS14 and KS15) from Eastern China have been detected 28 
 11 
carrying γ.γγ% and 1.67% mutant alleles, respectively, although both of them had low levels 1 
of resistance to abamectin. In general, heterozygous and homozygous mutant-type individuals 2 
with the Aγ09V mutation have been detected in field populations collected from China, but 3 
the reported mutations (GγβγD and Gγβ6E in TuGluCls) equivalent to Gγ15 position of 4 
PxGluCl have not been screened in the 17 field populations. 5 
4. Discussion 6 
 In this study we cloned and functionally expressed PxGluCl from an 7 
abamectin-susceptible strain of P. xylostella. The function and pharmacology of mutations 8 
relevant to abamectin resistance were also characterized. In addition, populations of 9 
abamectin-resistant P. xylostella were genotyped to detect the occurrence of mutations at the 10 
Aγ09 or Gγ15 positions in the field. We previously demonstrated that the Aγ09V mutation of 11 
PxGluCl was strongly associated with a 10-fold increase in abamectin resistance in P. 12 
xylostella Roth-Abm strain (Wang et al., β016b). Here we show by expressing the wild-type 13 
or Aγ09V channels in oocytes that the mutant exhibits a modest but significant (c.a.5-fold) 14 
reduction of abamectin sensitivity relative to the wild-type channel. This finding strongly 15 
suggests that target-site resistance indeed plays a role in abamectin resistance of P. xylostella 16 
pest populations in the field. 17 
 We hypothesized that Aγ09V may confer resistance by allosterically modifying the 18 
abamectin binding site (Wang et al., β016b). To investigate this further the Aγ09G and Aγ09I 19 
mutants were generated, as these residues have side chains that are either smaller or bigger 20 
than wild-type or Aγ09V. The Aγ09G mutation showed equivalent abamectin sensitivity 21 
compared with wild-type whereas the Aγ09I channel showed a 1.5-fold decrease in abamectin 22 
sensitivity, which contrasts with the 5-fold resistance exhibited by Aγ09V. Modelling of the 23 
receptor shows, as with Aγ09V (Wang et al., β016b), the Aγ09G and even the larger Aγ09I 24 
side chain can be accommodated without sterically perturbing the structure (Fig. 4). In 25 
addition, substitutions at the γ09 position are still too far from the abamectin binding site to 26 
interact directly with the ligand, further supporting the hypothesis of an allosteric mechanism 27 
underlying resistance.  28 
 12 
 Intriguingly, Aγ09 substitutions also affected glutamate sensitivity. A 1.7-fold reduction 1 
of glutamate sensitivity was detected with A309G, a 1.5-fold increase in sensitivity with 2 
A309V and surprisingly the A309I had increased glutamate sensitivity by one order of 3 
magnitude (12-fold). The 309 position is located on the top of the M3 helix and so distal from 4 
the glutamate binding site (see Fig. 6A in Wang et al., 2016b). Nevertheless, it is contiguous 5 
with the M2-M3 linker, which is critical for transmitting neurotransmitter-induced 6 
conformational changes in the extracellular domain to the transmembrane domain to gate the 7 
pore (Althoff et al., 2014). Degani-Katzav et al. (2016) identified a mutation in the 8 
IVE-binding site of M1 (αLβ79W; equivalent to α(-)L218 of CeGluCl crystal structure) that 9 
reduced the EC50 of glutamate by about 25-fold, when compared with the C. elegans wild 10 
type receptor. Similarly, Daeffler et al. (2014) introduced several mutant amino acids of 11 
varying size and polarity in to the M2 helix of C. elegans GluClȕ receptor, four of these 12 
mutations led to 9- to 44-fold increase in channel sensitivity to glutamate, respectively. In the 13 
current study, it appears that larger residues at the top of Mγ of PxGluCl facilitate channel 14 
opening, although the model reveals that the replacement of the alanine side chain with the 15 
larger isoleucine side chain didn't produce any steric clashes. Further studies will be required 16 
to determine why the A309I mutant is more sensitive to glutamate and to explain why the Hill 17 
coefficient has increased from 1.8 to 2.5, which suggests the presence of an additional 18 
glutamate binding site. Yet the effect of the A309I mutation clearly demonstrates the 19 
influence of this 309 position on GluCl pharmacology.  20 
 In the case of the A309V receptor, it is possible that this mutation does not allosterically 21 
modify the binding site for abamectin, thus inhibiting its binding. Instead this mutation may 22 
allosterically counteract the functional effect of the insecticide upon binding. We attempted to 23 
investigate this by quantifying binding affinity using radioligand binding studies of 24 
[3H]-avermectin to membranes of the PxGluCls expressed in Drosophila S2 cell lines. 25 
Unfortunately these studies were not successful, due to extremely high levels of nonspecific 26 
binding of [γH]-avermectin to membranes (data not shown). This is almost certainly due to the 27 
very lipophilic nature of the radioligand. A similar predicament was encountered when 28 
investigating the binding sites of pyrethroids on insect sodium channels (Rossignol, 1988; 29 
 13 
Pauron et al., 1989; Dong and Scott, 1994).  1 
 The current work also represents the first effort to characterize the pharmacological effect 2 
of naturally occurring G315E mutation. This mutation is tightly linked to abamectin 3 
resistance in the MAR-AB strain of T. urticae, with a resistance level of more than 2000-fold 4 
(Dermauw et al., 2012). The equivalent G323D mutation is associated with a 18-fold 5 
resistance to abamectinin an isogenic-resistant strain (Kwon et al., 2010). Our 6 
electrophysiology findings show that introducing the G315E mutation into PxGluCl resulted 7 
in 493-fold resistance to abamectin. Glycine is entirely conserved in M3 helix of GluCls and 8 
the role of substitutions at this“Mγ-Gly” position in conferring resistance to avermect in 9 
compounds has been well characterized (Lynagh and Lynch, 2012). Human glycine receptor 10 
α1 receptor (GlyRα1) has an alanine at the equivalent position and showed that 11 
IVE-sensitivity (50-fold) can be conferred on an IVE-insensitive receptor by introducing a 12 
M3-Gly at this position. Furthermore, the reciprocal introduction in the Haemonchus 13 
contortus αγBGluCl, Gγβ9A (the human GlyRα1 equivalent posotion) shifts the EC50 of IVE 14 
activation from γ9 nM up to 1β00 μM. This indicates that M3-Gly is essential for high IVE 15 
sensitivity in both glycine- and glutamate- gated Cys-loop receptors (Lynagh and Lynch, 16 
2010). The proposed resistance mechanism for M3-Gly mutations (Lynagh and Lynch, 2012) 17 
is that a larger side chain at this position sterically obstructs entry of an avermectin ligand to 18 
the narrow gap between the M3 helix of principal subunit and M1 of the complementary 19 
subunit and thus limits access to the insecticide binding site.  20 
 Recently, resistance to abamectin began to emerge and develop in field populations of 21 
various arthropod pests in worldwide, including twenty-one species form Lepidoperan, Acari, 22 
Blattodea, Coleoptera, Diptera, Hemiptera, Mesostigmata and Thysanoptera (APRD, 2017). 23 
Without doubt, identification of abamectin-resistant mutations will be very valuable for 24 
elucidating the molecular mechanisms and monitoring the development of resistance to 25 
abamectin. In this work, in total 503 larvae sampled from 17 field P. xylostella populations 26 
were analyzed for the estimation of the frequency of the A309V and G315D/E mutations, 27 
previously associated with abamectin resistance in arthropods. The A309V mutation was 28 
detected in four populations with lower frequencies. Two populations collected from Tonghai 29 
 14 
county in 2013 and 2016 (TH13, TH16), where abamectin was mainly employed in the 1 
control of P. xylostella and control failure always reported by local farmers, showed 6.25% 2 
and 10% mutant allele frequencies. In contrast, G315D/E has not been detected in any tested 3 
populations from China. Resistance development of field populations is complex, and 4 
resistant phenotype might be associated with metabolic detoxification of abamectin and other 5 
potential mechanisms. Although insecticide resistance development may or may not result in 6 
control failure, it has given rise to the loss of many selective compounds that could otherwise 7 
have formed part of insecticide resistance management (IRM) and, more broadly, integrated 8 
pest management programs for P. xylostella. In view of the A309V mutation detected in P. 9 
xylostella field populations, and the G314D and G326E mutations have been reported in T. 10 
urticae, originating from rose greenhouses with varied frequencies (from 5% to 100%) (Ilias 11 
et al., 2016), molecular diagnostic assays for early identification and monitoring of 12 
low-frequency A309V and G315D/E allelles of PxGluCl in a globally collected samples is 13 
required in IRM strategies of P. xylostella. 14 
 In conclusion, here we functionally characterized the potency of abamectin and the 15 
endogenous neurotransmitter glutamate on the activity of wild-type and mutant PxGluCls. 16 
Two naturally occurring mutations in the Mγ helix of arthropod GluCls that are associated 17 
with abamectin resistance reduced the channel sensitivity to this compound. We suggest that 18 
two different mechanisms are involved in abamectin target-site resistance, with the Gγ15 19 
mutation directly sterically hindering abamectin binding while the Aγ09V mutation possibly 20 
allosterically modifies the ligand binding site. Fitness analysis is required to define the 21 
physiological function and/or negative effects of these mutations on insects. Our study 22 
provide direct evidences that Aγ09V and Gγ15E mutations on Mγ helix can results in 23 
abamectin resistance, and we also suggest that resistant alleles should be monitored 24 
continuously, which will provide useful information for investigating the evolution and spread 25 
of well-characterized resistance genes. 26 
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Table 1 1 
Sequences of primers used in this study. 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
Primer Use Sequence (5' to 3') 
PxGluCl_EcoRI_F Full-length cDNA amplification and fusion PCR CGGAATTCGGTTTGCTGAGTTGGAGAATGGACG 
PxGluCl_XbaI_R Full-length cDNA amplification and fusion PCR GCTCTAGATGCCAGTGGAACGATGCTGATGC 
Px_A309V_F Amplify the downstream fragment of A to V mutation GTATCATACACAAAGGTCATAGACGTATGGACTGG 
Px_A309V_R Amplify the upstream fragment of A to V mutation CCAGTCCATACGTCTATGACCTTTGTGTATGATAC 
Px_A309I_F Amplify the downstream fragment of A to I mutation GTATCATACACAAAGATCATAGACGTATGGACTGG 
Px_A309I_R Amplify the upstream fragment of A to I mutation CCAGTCCATACGTCTATGATCTTTGTGTATGATAC 
Px_A309G_F Amplify the downstream fragment of A to G mutation GTATCATACACAAAGGGCATAGACGTATGGACTGG 
Px_A309G_R Amplify the upstream fragment of A to G mutation CCAGTCCATACGTCTATGCCCTTTGTGTATGATAC 
Px_G315E_F Amplify the downstream fragment of G to E mutation TAGACGTATGGACTGAGGTTTGTTTAACATTCG 
Px_G315E_R Amplify the upstream fragment of G to E mutation CGAATGTTAAACAAACCTCAGTCCATACGTCTA 
 20 
Table 2 1 
EC50 values and Hill coefficients of L-glutamate- and abamectin-induced responses of 2 
PxGluCls expressed in Xenopus laevis oocytes. Data were obtained by nonlinear regression 3 
analyses and indicated as means and 95% confidence limits (n = 5 ~ 6). 4 
 5 
Variants 
L-glutamate (μM)  Abamectin (μM) 
n EC50 95% CL nH 95%CL 
 
n EC50 95% CL nH 95%CL 
wild-type 6 19.93 17.43-22.79 1.8 1.4-2.1 
 
5 0.163 0.118-0.226 1.4 0.8-1.9 
A309V 6 13.24 11.73-14.94 1.0 0.9-1.1 
 
5 0.780 0.648-0.940 1.0 0.8-1.2 
A309I 6 1.673 1.514-1.847 2.5 2.0-2.9 
 
5 0.250 0.155-0.404 1.1 0.6-1.6 
A309G 6 34.60 27.47-43.60 0.7 0.6-0.8 
 
5 0.153 0.132-0.177 1.8 1.4-2.2 
G315E 6 10.35 8.689-12.33 1.0 0.9-1.2  5 80.320 53.87-119.7 0.5 0.4-0.6 
 21 
Table 3 1 
Levels of resistance to abamectin and the A309V mutation frequencies in field P. xylostella 2 
populations from China. 3 
 4 
Populations RFa N b 
A309V Mutation  
Ala/Ala Ala/Val Val/Val frequency (%)  
Pops. from Southwest China 
    
 
TH13 345 40 35 5 0 6.25  
MD13 491 36 36 0 0 0  
SH13 383 36 36 0 0 0  
TH16 92 20 16 4 0 10  
Pops. from Southeast China 
    
 
GZ14 49 30 30 0 0 0   
ZC14 151 30 30 0 0 0   
SZ14 253 30 30 0 0 0   
HZ14 162 30 30 0 0 0   
HK15 86 22 22 0 0 0   
Pops. from Eastern China 
   
 
NJ14 4.7 30 30 0 0 0   
HF14 12 30 30 0 0 0   
JN14 24 30 30 0 0 0   
KS14 3.1 30 29 0 1 3.33   
NJ15 14 30 30 0 0 0   
HF15 3.3 30 30 0 0 0   
JN15 2 30 30 0 0 0   
KS15 12 30 29 1 0 1.67   
a RF (resistance factor) = LC50 (resistant strain) ÷ LC50 (Roth). Unpublished data. 
b
 Number of insects genotyped. A, alanine (Ala); V, valine (Val). 
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 1 
 2 
Fig. 1. Alignment of the amino acid sequences in transmembrane domain β and γ of glutamate-gated chloride channel genes of C. elegans 3 
(CeGluCl, GenBank accession code AAA50785.1 ), D. melanogaster (DmGluCl, GenBank accession codeU58776.1), T. urticae (TuGluCl1, 4 
TuGluClγ, GenBank accession code XM_0159γ88βγ.1 and NP_001γ10061.1) and P. xylostella (PxGluCl-WT, PxGluCl-Aγ09V, PxGluCl-Aγ09I, 5 
PxGluCl-Aγ09G, PxGluCl-Gγ15E).Fully conserved resides are shaded in black, while lower similar positions are shaded in grey. The Pββ9S, 6 
Gγ14D and Gγβ6E mutations in DmGluCl, TuGluCl1 and TuGluClγ, associated with ivermectin/abamectin resistance, are indicated in blue 7 
(Kane et al., β000; Kwon et al., β010; Dermauw et al., β01β). The Aγ09V mutation in PxGluCl associated with abamectin resistance (Wang et al., 8 
β016b) and the introduced Aγ09I/G and Gγ15E substitutes in this study are indicated in red. 9 
 23 
 1 
Fig. 2. Glutamate responses of wild- and mutant-type homomeric PxGluCls expressed in 2 
Xenopus oocytes. (A) Traces of electrical responses induced by L-glutamate from the 3 
wild-type ion channels. (B) Normalized dose-response curves for glutamate induced currents 4 
for oocytes expressing wild-type, Aγ09V, Aγ09I, Aγ09G and Gγ15E mutant channels. The 5 
data are means ± SEM (n = 6). 6 
 24 
 1 
Fig. 3. Abamectin responses of wild- and mutant-type homomeric PxGluCls expressed in 2 
Xenopus oocytes. (A) Examples of electrical responses induced by saturated glutamate (100 3 
μM) and abamectin (1μM) in the wild-type, Aγ09V and Gγ15E mutant ion channels, 4 
respectively. (B) Normalized dose-response curves for abamectin induced currents for oocytes 5 
expressing wild-type, Aγ09V, Aγ09I, Aγ09G and Gγ15E mutant channels. The data are means 6 
± SEM (n = 5). 7 
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 1 
Fig. 4. Models of wild-type PxGluCl and Aγ09 mutations. Side view of the transmembrane 2 
domain with channel monomers shown as cartoon. The γ09 position is shown in black 3 
spacefill and abamectin is shown as yellow sticks with a transparent surface. 4 
 26 
 1 
Fig. 5. Models of wild-type PxGluCl and the Gγ15 Emutation. Side view and extracellular 2 
view of the abamectin binding site with channel monomers shown as cartoon. The γ15 3 
position is shown in black spacefill and abamectin is as yellow sticks with a transparent 4 
surface.  5 
